复方新诺明注射液
生产厂家：瑞士罗氏制药公司
功能主治：敏感菌株所致的上呼吸道感染和泌尿感染
用法用量：用法用量 1.2个月以上的儿童和成人常用剂量 (1)肺孢子菌肺炎(卡氏肺孢子虫肺炎)：15-20 mg/kg，分 2 ～ 3 次使用，间隔6-8个小时使用1次，连续使用4天。 (2)由福氏或宋氏志贺菌敏感菌株所致的肠道感染、志贺菌感染：8-10 mg/kg，分 2 ～ 4 次使用，间隔6-8个小时或12小时使用1次，连续使用14天。 (3)大肠埃希菌、克雷伯菌属、肠杆菌属、奇异变形杆菌、普通变形杆菌和莫根菌属敏感菌株所致的尿路感染：8-10 mg/kg，分 2 ～ 4 次使用，间隔6-8个小时或12小时使用1次，连续使用5天。 2.肾功能受损患者的常用剂量(根据肌酐清除率判断剂量) (1)肌酐清除率>30ml/分钟：同常规剂量 (2)肌酐清除率15~30ml/分钟：常规剂量减半 (3)肌酐清除率<15ml/分钟：不推荐使用
查看详情
正文：
复方新诺明注射液，又称为Bactrim，是由复方新诺明（sulfamethoxazole）和甲氧苄啶（trimethoprim）两种抗感染药物组成的复合制剂。该药有效地治疗了上呼吸道感染和泌尿感染等多种感染疾病。相比于其他药物，复方新诺明注射液在治疗感染过程中具有较低的耐药性和较少的副作用。复方新诺明注射液包含的复方新诺明和甲氧苄啶具有不同的作用机制。复方新诺明是一种糖皮质激素抑制剂，通过阻断细菌在细胞代谢中所需的二氢叶酸的产生，从而抑制菌落的增殖。而甲氧苄啶是一种抑制细菌细胞色素还原酶和二氢叶酸合成酶的抗菌药物。两种药物的协同作用，使得复方新诺明注射液在抑制多种敏感细菌的生长方面效果显著。
复方新诺明注射液适用于特定敏感菌株所致的感染，如大肠杆菌、副溶血弧菌、空肠弯曲菌等。它可用于治疗上呼吸道感染（如鼻窦炎、中耳炎等）和泌尿感染（如膀胱炎、肾盂肾炎等）等常见的感染疾病。该药能快速控制感染症状，减轻疼痛和炎症，促进患者康复。
然而，由于种种原因，复方新诺明注射液在国内市场上并不普遍。这导致了许多有需求的人们选择通过国外代购的方式来获得该药品。国外代购可以通过正规渠道，通过认证的网络药店或国外亲友的帮助进行。在代购时，需注意选购信誉良好的供应商，并确保所购买的产品是符合国内药品监管要求的。
总结：
复方新诺明注射液作为一种高效抗生素，可用于特定敏感菌株所致的感染疾病。在治疗上呼吸道感染和泌尿感染等常见感染疾病时，该药物表现出良好的疗效。尽管复方新诺明注射液在国内市场上不易获得，但通过国外代购的方式，我们可以便捷地获得该药，并得到及时有效的治疗。但在进行代购时，务必选择可信赖的渠道，以保证所购买的产品的品质和合法性。
参考译文：
Title: Overseas purchasing of Bactrim: A Good Choice for Treating Infections
Introduction: Bactrim, also known as Bactrim, is a widely-used and efficient antibiotic overseas, which is suitable for various infections caused by specific sensitive strains, such as upper respiratory tract infections and urinary tract infections. For infections caused by certain sensitive strains, Bactrim is an effective treatment option. However, due to various reasons, the drug is not available on the domestic market, leading to many people choosing to purchase it overseas.
Text:
Bactrim, or Bactrim, is a compound preparation composed of sulfamethoxazole and trimethoprim, two anti-infective drugs. This drug effectively treats various infections, such as upper respiratory tract infections and urinary tract infections. Compared to other drugs, Bactrim has a lower resistance and fewer side effects during the treatment of infections.
Bactrim injection solution contains sulfamethoxazole and trimethoprim, which have different mechanisms of action. Sulfamethoxazole is a glucocorticoid inhibitor that blocks the production of dihydrofolate bacteria need for cell metabolism, thereby inhibiting bacterial proliferation. Trimethoprim is an antibacterial drug that inhibits bacterial cytochrome reductase and dihydrofolate synthase. The synergy between these two drugs makes Bactrim injection solution remarkably effective in inhibiting the growth of multiple susceptible bacteria.
Bactrim injection solution is suitable for infections caused by specific sensitive strains, such as Escherichia coli, Vibrio parahaemolyticus, and Enterobacter cloacae, among others. It can be used to treat common infectious diseases such as upper respiratory tract infections (e.g., sinusitis, otitis media, etc.) and urinary tract infections (e.g., cystitis, pyelonephritis, etc.). This medication can quickly control infection symptoms, alleviate pain and inflammation, and promote patient recovery.
However, due to various reasons, Bactrim injection solution is not widely available on the domestic market. This has led many people in need to choose to purchase it through overseas channels. When purchasing it overseas, it is important to choose reputable suppliers and ensure that the products purchased meet the requirements of domestic drug regulations.
Conclusion:
Bactrim injection solution is an efficient antibiotic suitable for infections caused by specific sensitive strains. It exhibits good therapeutic effects in the treatment of common infectious diseases such as upper respiratory tract infections and urinary tract infections. Although Bactrim injection solution is not easy to obtain on the domestic market, by purchasing it overseas, we can obtain the medication conveniently and receive timely and effective treatment. However, when making overseas purchases, it is essential to choose trusted channels to ensure the quality and legitimacy of the products purchased.
